Controlled clinical trial of four short-course (6-month) regimens of chemotherapy for treatment of pulmonary tuberculosis. Second report.

Suppr

超能文献

出版信息

Lancet. 1973 Jun 16;1(7816):1331-8.

PMID:4122738

Abstract

摘要

相似文献

Controlled clinical trial of four short-course (6-month) regimens of chemotherapy for treatment of pulmonary tuberculosis. Second report.

Lancet. 1973 Jun 16;1(7816):1331-8.

Controlled clinical trial of short-course (6-month) regimens of chemotherapy for treatment of pulmonary tuberculosis.

Lancet. 1972 May 20;1(7760):1079-85.

Controlled clinical trial of four short-course (6-month) regimens of chemotherapy for treatment of pulmonary tuberculosis.

Lancet. 1974 Nov 9;2(7889):1100-6.

Controlled clinical trial of four short-course (6-month) regimens of chemotherapy for treatment of pulmonary tuberculosis. Third report. East African-British Medical Research Councils.四种短程（6个月）化疗方案治疗肺结核的对照临床试验。第三次报告。东非-英国医学研究委员会

Lancet. 1974 Aug 3;2(7875):237-40.

Comparison of various drug regimens in domiciliary chemotherapy.家庭化疗中不同药物治疗方案的比较。

Am Rev Respir Dis. 1970 Oct;102(4):607-13. doi: 10.1164/arrd.1970.102.4.607.

Controlled trial of 2, 4, and 6 months of pyrazinamide in 6-month, three-times-weekly regimens for smear-positive pulmonary tuberculosis, including an assessment of a combined preparation of isoniazid, rifampin, and pyrazinamide. Results at 30 months. Hong Kong Chest Service/British Medical Research Council.对痰涂片阳性肺结核患者采用每周三次、为期6个月的治疗方案，比较2个月、4个月和6个月吡嗪酰胺使用时间的对照试验，包括对异烟肼、利福平及吡嗪酰胺复方制剂的评估。30个月时的结果。香港胸科服务处/英国医学研究委员会

Am Rev Respir Dis. 1991 Apr;143(4 Pt 1):700-6. doi: 10.1164/ajrccm/143.4_Pt_1.700.

Short-course treatment in pulmonary tuberculosis.肺结核的短程治疗。

East Afr Med J. 1973 Dec;50(12):672-80.

Short-course chemotherapy for pulmonary tuberculosis.肺结核的短程化疗

Am Rev Respir Dis. 1975 Mar;111(3):325-53. doi: 10.1164/arrd.1975.111.3.325.

A controlled trial of a 4-weekly supplement of rifampicin, pyrazinamide and streptomycin in the continuation phase of a 7-month daily chemotherapy regimen for pulmonary tuberculosis. Tanzania/British Medical Research Council Collaborative Investigation.一项针对肺结核患者的研究，该研究采用为期7个月的每日化疗方案，在持续治疗阶段每四周补充利福平、吡嗪酰胺和链霉素，并进行对照试验。坦桑尼亚/英国医学研究理事会合作调查。

S Afr Med J. 1996 Aug;86(8):960-5.

Assessment of a daily combined preparation of isoniazid, rifampin, and pyrazinamide in a controlled trial of three 6-month regimens for smear-positive pulmonary tuberculosis. Singapore Tuberculosis Service/British Medical Research Council.在一项针对涂片阳性肺结核的三种6个月治疗方案的对照试验中，对异烟肼、利福平及吡嗪酰胺每日联合制剂的评估。新加坡结核病防治所/英国医学研究委员会

Am Rev Respir Dis. 1991 Apr;143(4 Pt 1):707-12. doi: 10.1164/ajrccm/143.4_Pt_1.707.

引用本文的文献

Brain Tuberculosis: An Odyssey through Time to Understand This Pathology.脑结核：穿越时空了解这种病理状况的历程

Pathogens. 2023 Aug 9;12(8):1026. doi: 10.3390/pathogens12081026.

The human proton pump inhibitors inhibit rifampicin efflux and macrophage-induced rifampicin tolerance.人质子泵抑制剂抑制利福平外排和巨噬细胞诱导的利福平耐受。

Proc Natl Acad Sci U S A. 2023 Feb 14;120(7):e2215512120. doi: 10.1073/pnas.2215512120. Epub 2023 Feb 10.

Tools to develop antibiotic combinations that target drug tolerance in .开发针对抗生素耐药性的抗生素联合用药的工具。

Front Cell Infect Microbiol. 2023 Jan 6;12:1085946. doi: 10.3389/fcimb.2022.1085946. eCollection 2022.

Tuberculosis sanatorium treatment at the advent of the chemotherapy era.抗结核化学药物治疗时代以前的疗养院治疗。

BMC Infect Dis. 2020 Nov 11;20(1):831. doi: 10.1186/s12879-020-05539-w.

A comprehensive characterization of PncA polymorphisms that confer resistance to pyrazinamide.对赋予吡嗪酰胺抗性的PncA多态性的全面表征。

Nat Commun. 2017 Sep 19;8(1):588. doi: 10.1038/s41467-017-00721-2.

Coadministration of Allopurinol To Increase Antimycobacterial Efficacy of Pyrazinamide as Evaluated in a Whole-Blood Bactericidal Activity Model.别嘌醇联合给药以提高吡嗪酰胺的抗分枝杆菌疗效：全血杀菌活性模型评估。

Antimicrob Agents Chemother. 2017 Sep 22;61(10). doi: 10.1128/AAC.00482-17. Print 2017 Oct.

Inhaled Pyrazinoic Acid Esters for the Treatment of Tuberculosis.吸入式吡嗪酸酯用于治疗结核病。

Pharm Res. 2016 Oct;33(10):2495-505. doi: 10.1007/s11095-016-1974-5. Epub 2016 Jun 28.

JAID/JSC Guidelines for the Treatment of Respiratory Infectious Diseases: The Japanese Association for Infectious Diseases/Japanese Society of Chemotherapy - The JAID/JSC Guide to Clinical Management of Infectious Disease/Guideline-preparing Committee Respiratory Infectious Disease WG.日本传染病学会/日本化疗学会《呼吸道传染病治疗指南》：日本传染病学会/日本化疗学会传染病临床管理指南/指南编写委员会呼吸道传染病工作组

J Infect Chemother. 2016 Jul;22(7 Suppl):S1-S65. doi: 10.1016/j.jiac.2015.12.019. Epub 2016 Jun 15.

Challenges in the clinical assessment of novel tuberculosis drugs.新型结核病药物临床评估中的挑战。

Adv Drug Deliv Rev. 2016 Jul 1;102:116-22. doi: 10.1016/j.addr.2016.01.014. Epub 2016 Jan 28.

Contribution of moxifloxacin or levofloxacin in second-line regimens with or without continuation of pyrazinamide in murine tuberculosis.莫西沙星或左氧氟沙星二线方案的疗效与是否继续应用吡嗪酰胺在鼠结核中的作用。

Am J Respir Crit Care Med. 2013 Jul 1;188(1):97-102. doi: 10.1164/rccm.201212-2328OC.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验